Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nuvectis Pharma, Inc. | 1,806,319 | reported | 06 Jan 2026 | tx 12+613,270 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | GRANT_AWARD | Nuvectis Pharma, Inc. | 150,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Nuvectis Pharma, Inc. | 150,000 | 0.00 USD | |
| 19 Nov 2024 | PURCHASE | Nuvectis Pharma, Inc. | 2,000 | 4.99 USD | |
| 10 May 2024 | PURCHASE | Nuvectis Pharma, Inc. | 500 | 6.29 USD | first after silence |
| 03 Jan 2024 | GRANT_AWARD | Nuvectis Pharma, Inc. | 130,000 | 0.00 USD | |
| 27 Mar 2023 | PURCHASE | Nuvectis Pharma, Inc. | 500 | 11.55 USD | |
| 12 Jan 2023 | GRANT_AWARD | Nuvectis Pharma, Inc. | 115,000 | 0.00 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 300 | 16.04 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 370 | 14.76 USD | |
| 01 Apr 2022 | GRANT_AWARD | Nuvectis Pharma, Inc. | 60,000 | 0.00 USD | |
| 07 Feb 2022 | PURCHASE | Nuvectis Pharma, Inc. | 800 | 3.88 USD | |
| 04 Feb 2022 | PURCHASE | Nuvectis Pharma, Inc. | 3,800 | 3.35 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 May 2024.